Researchers are currently investigating whether a combined cannabigerol (CBG) and cannabidiol (CBD) oil may help people experiencing chemotherapy‑induced peripheral neuropathy (CIPN)—a condition that can cause pain, numbness, tingling, and sensitivity in the hands and feet after cancer treatment. This clinical study, registered with the U.S. National Institutes of Health, is designed to understand if CBG/CBD […]
Category: CBG
Cannabinoids Show Selective Antibacterial Effects Against Persistent Dental Infections (pub. Dec 2025)
Persistent endodontic infections—often associated with failed root canal treatments—are commonly caused by bacteria that survive traditional disinfection methods and develop resistance to standard antimicrobial therapies. In this laboratory study, researchers examined whether cannabinoids, including cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC), could inhibit bacteria frequently found in chronic dental infections. The study focused on Enterococcus […]
CBD and CBG as Adjunct Support for Trigeminal Neuralgia and Postherpetic Pain (pub. Oct. 2025)
Trigeminal neuralgia and postherpetic neuralgia are forms of neuropathic facial pain that can cause intense, persistent burning or stabbing sensations and are often difficult to manage with conventional medications alone. This clinical case report examined the use of cannabidiol (CBD) and cannabigerol (CBG) as supportive therapies in a patient whose symptoms did not respond adequately […]